Craneware plc Trading Update and Notice of Results (7769X)
16 Gennaio 2014 - 8:00AM
UK Regulatory
TIDMCRW
RNS Number : 7769X
Craneware plc
16 January 2014
Craneware plc
("Craneware", "the Group" or the "Company")
Trading Update and Notice of Results
16 January 2014 - Craneware (AIM: CRW.L), the market leader in
automated revenue integrity solutions for the US healthcare market,
provides an update on trading for the six months ended 31 December
2013.
The Group has continued to see positive momentum in sales
through the period, driven by a strengthened sales operation and
supportive market environment. The majority of revenue and margin
resulting from sales in the period will be recognised over future
periods as per the Company's normal revenue recognition policy,
adding to the Group's long term visibility of revenue under
contract.
The Company expects to report recognised revenue and EBITDA
increases of 5% for the six months ended 31 December 2013 compared
with the same period last fiscal year. This is in line with
management's expectations for the H1 to H2 split, which, together
with the continuing positive sales momentum, provides the board
with confidence in meeting market expectations for the full
year.
Keith Neilson, CEO of Craneware plc commented, "The continued
incremental increases in the size of hospital groups, overall deal
size and increasing number of longer term contracts signed during
the period provided a strong sales performance and resulted in
recognised revenue and EBITDA growth. Importantly, the increased
sales activity will flow through into revenue and EBITDA
contribution in the second half of the year and beyond, providing
further visibility over future contracted revenues and supporting
continued growth."
The Company will announce its Interim Results on 11 March
2014.
For further information, please contact:
Craneware plc Peel Hunt Newgate Threadneedle
+44 (0)131 550 3100 +44 (0)20 7418 8900 +44 (0)20 7653 9850
Keith Neilson, CEO Dan Webster Caroline Evans-Jones
Craig Preston, CFO Richard Kauffer Fiona Conroy
Heather Armstrong
About Craneware
Founded in 1999, Craneware has headquarters in Edinburgh,
Scotland with offices in Atlanta, Arizona, Massachusetts and
Tennessee employing over 200 staff. Craneware is the leader in
automated revenue integrity solutions that improve financial
performance for healthcare organisations. Craneware's
market-driven, SaaS solutions help hospitals and other healthcare
providers more effectively price, charge, code and retain earned
revenue for patient care services and supplies. This optimises
reimbursement, increases operational efficiency and minimises
compliance risk. By partnering with Craneware, clients achieve the
visibility required to identify, address and prevent revenue
leakage. To learn more, visit craneware.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTEAPFSFASLEFF
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Craneware (LSE:CRW)
Storico
Da Lug 2023 a Lug 2024